Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions

Catheter Cardiovasc Interv. 2004 Oct;63(2):177-82; discussion 183. doi: 10.1002/ccd.20109.

Abstract

Angiographic thrombus is associated with poorer procedural and clinical outcomes. We report our experience with the X-Sizer thrombectomy device (EndiCOR Medical) from March 2001 to December 2002. Indications for use in 44 patients (33 male; mean age, 60) included myocardial infarction (27), unstable angina (6), periprocedural thrombosis (2), acute (< 24 hr) stent thrombosis (1), and subacute (> 24 hr) stent thrombosis (8). Three cases involved vein grafts. Deployment was successful in 42/44. Difficulty traversing the stent occurred in 5/9 cases of in-stent thrombosis. Median TIMI flow increased from 1 to 2 (P = 0.01) postthrombectomy. Median final TIMI flow was 3. Complications included dissection (1), perforation, device jam on stent (1), disruption of a covered stent (1), distal macro-embolization (4), and transient no-reflow (5). The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis.

MeSH terms

  • Cardiac Catheterization / instrumentation*
  • Coronary Thrombosis / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications
  • Statistics, Nonparametric
  • Stents*
  • Thrombectomy / instrumentation*
  • Treatment Outcome